There is one clinical trial.
The purpose of this study is to asses the efficacy of the Gammacore device reducing the need
for mechanical ventilation in patients diagnosed of Covid-19
Primary Outcomes
Measure: Need for mechanical ventilation Time: From randomization to hospital discharge or ICU admission, whatever occurs first, assessed up to two months
Secondary Outcomes
Measure: Supplemental oxygen requirements Time: From randomization to hospital discharge or ICU admission, whatever occurs first, assessed up to two months
Measure: Mortality Time: From randomization to hospital discharge or ICU admission, whatever occurs first, assessed up to two months
Measure: Delay onset of ventilation Time: From randomization to the day of need for mechanical ventilation or hospital discharge, whatever occurs first, assessed up to two months
Measure: Cytokine levels Time: From randomization to hospital discharge or ICU admission, whatever occurs first, assessed up to two months